Two centuries. Countless innovations. One vision.
Takeda Disclosure Reports 2021
EFPIA Self-Certification Letter
Given the current situation in Ukraine, EFPIA decided to suspend the disclosure requirements in that country for the 2022 disclosure of 2021 data
Copyright 1995-2023 Takeda Pharmaceutical Company Limited. All rights reserved.